Jiangsu Sihuan Bioengineering Co.,Ltd
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Jiangsu Sihuan Biological Co., Ltd. (hereinafter referred to as the Company or the Company), formerly known as Jiangsu Sanshan Industrial Co., Ltd. (hereinafter referred to as "Jiangsu Sanshan"), was established on May 18, 1992. On April 26, 1993, with the approval of the State Commission for Restructuring and Reform (1992) No. 87 and the Jiangsu Provincial People's Government's Su Zhengfu (1992) No. 62, the company publicly issued 40 million A-shares to the public and was listed on the Shenzhen Stock Exchange. On September 17, 2001, the company was approved by the China Securities Regulatory Commission's Zheng Jian Fa Fa Zi [2001] No. 80 document to issue an additional 45 million RMB ordinary shares, and was listed on the Shenzhen Stock Exchange on November 20, 2001. The company's stock name is "Sihuan Bio" and the stock code is "000518". According to the resolution of the 2001 shareholders' meeting, the company implemented a bonus stock of 0.3 shares per 10 shares on March 25, 2002, and increased the capital reserve by 5.7 shares per 10 shares. After the transfer of shares, the company's share capital was 285987840 shares. According to the resolution of the second extraordinary general meeting of shareholders in 2002, the company implemented a capital increase plan of 8 shares per 10 shares using capital reserve on August 28, 2002. After the increase, the company's share capital was 514778111 shares. According to the resolution of the second extraordinary general meeting of shareholders in 2003, in August 2003, based on the total share capital of 514778111 shares as of June 30, 2003, the company issued 2.3 bonus shares per 10 shares with distributable profits, and increased 7.7 shares per 10 shares with capital reserve. After the issuance, the company's share capital was 1029556222 shares. In November 2006, our company completed the equity split reform. The consideration paid by non tradable shareholders of our company to obtain the right to circulate their non tradable shares is 0.8 shares for every 10 tradable shares obtained by non tradable shareholders. After implementing the above consideration, the total number of shares in the company remains unchanged and the share structure undergoes corresponding changes. As of December 31, 2017, the total share capital was 1029556222 shares, including 20529 shares with limited sales conditions, accounting for 0.00% of the total shares, and 1029535693 shares with unlimited sales conditions, accounting for 100.00% of the total shares. The unified social credit code of the company is 913202001381477183. The company belongs to the pharmaceutical industry, with main products such as injections and pharmaceuticals. Legal representative of the company: Sun Guojian, registered in Binjiang Development Zone, Jiangyin City, Jiangsu Province, with headquarters located in Binjiang Development Zone, Jiangyin City. The company's business scope includes: large capacity injections (including multi-layer co extruded film infusion bags), small capacity injections (including anti-tumor drugs), tablets (including anti-tumor drugs), hard capsules, syrups, oral solutions, alcoholic beverages, raw materials, traditional Chinese medicine extraction, and the production of Class II psychotropic drugs; Subpackaging of Xueyu Bone Treasure (capsules, tablets), Borteng brand Naocofei capsules, and Yinman Gold Selenized Spirulina tablets; Medical information consultation; Technology transfer services; Manufacturing of pharmaceutical intermediates (excluding hazardous chemicals); Manufacturing and sales of woolen fabrics, cashmere products, knitwear, chemical fibers, and chemical products (excluding dangerous goods);; Sales of electronic products, communication, and broadcasting and television equipment (excluding satellite television broadcasting ground reception facilities and transmission devices); industrial investment Engage in the export business of our own products and technologies, import business of raw and auxiliary materials, instruments and meters, mechanical equipment, spare parts and technologies required for our production and scientific research (excluding goods and technologies that are restricted by the state and prohibited from import and export), and engage in processing of imported materials and the "three supplies and one supplement" business; Landscape greening engineering. |
| Headquarter | Wuxi |
| Establish Date | 5/18/1992 |
| Listed Code | 000518.SZ |
| Listed Date | 9/8/1993 |
| Chairman | Guo Yu. |
| CEO | Guo Yu. |
| Website | www.000518shsw.com |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
